"Ideal Body Weight" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Expected weight of a healthy normal individual based on age, sex, and height. Thus, a malnourished person would weigh less than their ideal body weight.
| Descriptor ID |
D056865
|
| MeSH Number(s) |
E01.370.600.115.100.160.120.499 E05.041.124.160.750.650 G07.100.100.160.120.499 G07.345.249.314.120.650
|
| Concept/Terms |
Ideal Body Weight- Ideal Body Weight
- Body Weight, Ideal
- Body Weights, Ideal
- Ideal Body Weights
- Weight, Ideal Body
- Weights, Ideal Body
- Normal Body Weight
- Body Weight, Normal
- Body Weights, Normal
- Normal Body Weights
- Weight, Normal Body
- Weights, Normal Body
- Ideal Body Mass
- Body Mass, Ideal
- Body Masses, Ideal
- Ideal Body Masses
- Mass, Ideal Body
- Masses, Ideal Body
|
Below are MeSH descriptors whose meaning is more general than "Ideal Body Weight".
Below are MeSH descriptors whose meaning is more specific than "Ideal Body Weight".
This graph shows the total number of publications written about "Ideal Body Weight" by people in this website by year, and whether "Ideal Body Weight" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2015 | 1 | 0 | 1 |
| 2018 | 2 | 0 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Ideal Body Weight" by people in Profiles.
-
Adipose Tissue Insulin Resistance in Youth on the Spectrum From Normal Weight to Obese and From Normal Glucose Tolerance to Impaired Glucose Tolerance to Type 2 Diabetes. Diabetes Care. 2019 02; 42(2):265-272.
-
The "Ideal" Body Weight for Pediatric Gentamicin Dosing in the Era of Obesity: A Population Pharmacokinetic Analysis. Ther Drug Monit. 2018 06; 40(3):322-329.
-
PTEN loss is a context-dependent outcome determinant in obese and non-obese endometrioid endometrial cancer patients. Mol Oncol. 2015 Oct; 9(8):1694-703.